Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Cooper

Showing results (1-10 of 399) with videos related to

Pageof 40
Sort By:
American Journal of Hypertension|November 13, 2004
The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complicationsMark E Cooper
Nature Reviews. Endocrinology|July 25, 2012
Diabetes: treating diabetic nephropathy-still an unresolved issueMark E Cooper
Pediatric Diabetes|October 24, 2006
Is diabetic nephropathy disappearing from clinical practice?Mark E Cooper
Pediatric Diabetes|June 4, 2009
Metabolic memory: implications for diabetic vascular complicationsMark E Cooper
Diabetes & Vascular Disease Research|October 12, 2010
DIRECT study: a commentaryMark E Cooper
American Journal of Hypertension|December 21, 2004
Importance of advanced glycation end products in diabetes-associated cardiovascular and renal diseaseMark E Cooper
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 10, 2013
Choosing the right angiotensin-receptor blocker for patients with diabetes: still controversialMark E Cooper
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|November 5, 2008
Diabetic patients and kidney protection: an attainable targetDavid Barit, Mark E Cooper
Nature Reviews. Nephrology|August 13, 2021
Potential cardiorenal benefits of efpeglenatide in diabetesJacques Ma, Mark E Cooper
The New England Journal of Medicine|October 10, 2008
UKPDS and the legacy effectJohn Chalmers, Mark E Cooper
Pageof 40

Showing results (1-10 of 399) with videos related to

Sort By:
Pageof 40
American Journal of Hypertension|November 13, 2004
The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complicationsMark E Cooper
Nature Reviews. Endocrinology|July 25, 2012
Diabetes: treating diabetic nephropathy-still an unresolved issueMark E Cooper
Pediatric Diabetes|October 24, 2006
Is diabetic nephropathy disappearing from clinical practice?Mark E Cooper
Pediatric Diabetes|June 4, 2009
Metabolic memory: implications for diabetic vascular complicationsMark E Cooper
Diabetes & Vascular Disease Research|October 12, 2010
DIRECT study: a commentaryMark E Cooper
American Journal of Hypertension|December 21, 2004
Importance of advanced glycation end products in diabetes-associated cardiovascular and renal diseaseMark E Cooper
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 10, 2013
Choosing the right angiotensin-receptor blocker for patients with diabetes: still controversialMark E Cooper
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|November 5, 2008
Diabetic patients and kidney protection: an attainable targetDavid Barit, Mark E Cooper
Nature Reviews. Nephrology|August 13, 2021
Potential cardiorenal benefits of efpeglenatide in diabetesJacques Ma, Mark E Cooper
The New England Journal of Medicine|October 10, 2008
UKPDS and the legacy effectJohn Chalmers, Mark E Cooper
Pageof 40